Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 967 of 6351
-
New program aims to keep teens off opioids with medication and support
Disease control Recruiting nowThe Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to…
Phase 4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Proton beams may ease brain tumor treatment side effects
Symptom relief Recruiting nowRadiation therapy is an integral part of the multimodal primary therapy of glioblastomas. As the overall prognosis in this tumor entity remains unfavorable, current research is focused on additional drug therapies, which are often accompanied by increases in toxicity. By using pr…
Sponsor: University Hospital Heidelberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Could a simple shot prevent brain bleeding after a fall?
Disease control Recruiting nowTranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
Phase 3 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can sound, heat, and pressure rewire the depressed brain?
Symptom relief CompletedMajor depressive disorder (MDD) is associated with dysfunction across large-scale brain networks and remains insufficiently responsive to existing treatments in many patients. While most therapeutic strategies target top-down cortical modulation, bottom-up sensory interventions r…
Sponsor: Shalvata Mental Health Center • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New surgery trial aims to restore vision after macular bleeding
Disease control Recruiting nowThe centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for reading and recognising faces. These cells can be damaged by a disease called wet age-related macular degeneration (AMD), where new abnormal blood vessels grow …
Phase 3 • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Heated chemo combo could tame stomach cancer spread
Disease control Recruiting nowThis is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology ap…
Phase 2 • Sponsor: Banner Health • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New targeted therapy shows promise for Hard-to-Treat lung cancer
Disease control OngoingThis phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to …
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
MRNA therapy takes on rare metabolic disease
Disease control Recruiting nowThis 3-part, Phase 1/2 study is designed to characterize the safety, tolerability, and pharmacological activity (as assessed by biomarker measurements) and to determine the selected dose of mRNA-3927 in participants with genetically confirmed propionic acidemia (PA). After establ…
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Custom-Made vaccine takes on liver cancer after surgery
Disease control Recruiting nowThis is a single arm phase II study of adjuvant intra-dermal NA DC vaccine combined with intravenous nivolumab in patients with resectable HCC (group A) or CRLM (group B) planned for curative surgery (with/without local ablation).
Phase 2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New hope for rare kidney disease: drug targets oxalate buildup in severe cases
Disease control Recruiting nowThe aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.
Phase 2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Teens with HIV get boost from phone apps and peer helpers in nigeria
Disease control CompletedCombination interventions with mHealth and Peer Navigation components will be evaluated in a randomized, stepped wedge trial among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study findings will demonstrate whether or not the combination interventions for HIV treatment outc…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a short drug course end malaria relapses for good?
Cure CompletedThe study will be an open-labelled randomized clinical trial to determine therapeutic efficacy. Note that this will not be an Investigational New Drug application, as only World Health Organization (WHO)-approved drugs will be used at dosage and for conditions approved.
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Cure
Last updated Jun 27, 2026 13:00 UTC
-
Blood test and AI could spot liver cancer early, saving lives
Knowledge-focused OngoingHepatocellular carcinoma (HCC) is the 7th most common cause of cancer death globally but only 20% are diagnosed in its early stages where cure is possible. Current standard-of-care surveillance of patients at high risk of developing HCC with 6-monthly serum alpha-fetoprotein (AFP…
Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New study seeks best drug combo for kidney disease
Disease control Recruiting nowThe primary objective of this study is to compare the 24 month remission of different immunosuppressive therapies in the treatment of idiopathic membranous nephropathy (iMN)
Phase 3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New enzyme replacement therapy aims to stop dangerous blood clots in rare disease
Disease control OngoingThrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to the body's organs, such as the brain, kidneys, and heart. As a result, serious he…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Magic mushroom compound tested for dual depression and alcohol problems
Disease control OngoingThe purpose of this study is to determine whether psilocybin, a hallucinogenic drug, is effective in reducing depressive symptoms and amount of drinking in patients with co-occurring Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Personalized vaccine shows promise in Tough-to-Treat breast cancer trial
Disease control Recruiting nowThis phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in treating patients with triple negative breast cancer that has spread from where it first started (primary si…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New heart valve could spare congenital patients from repeat surgeries
Disease control OngoingThis study will monitor device performance and outcomes of the SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract (RVOT) conduit or previously implanted surgical valve in the pulmonic position with a clinical indicatio…
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Heart pump may boost survival in complex stenting
Disease control OngoingThe purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current st…
Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
AI takes on mammograms: 100,000 women test smarter screening
Diagnosis CompletedThe purpose of this randomized controlled trial is to assess whether AI can improve the efficacy of mammography screening, by adapting single and double reading based on AI derived cancer-risk scores and to use AI as a decision support in the screen reading, compared with convent…
Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC